86.22.Z - Specialist medical practice
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46 - Wholesale trade
47 - Retail trade
58 - Publishing activities
66 - Activities supporting financial services, insurance, and pension funds
66.19.Z - Other activities supporting financial services, excluding insurance and pension funds
68 - Real estate activities
70 - Head office activities and management consultancy
86 - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,2 | 6 | ||
Gross profit (loss) | 0,4 | -1,8 | -0,7 | 60,7 |
EBITDA | 0,7 | -1,3 | 0 | 100,4 |
Short time liabilities | 1,7 | 4,4 | 4,6 | 2,8 |
Other operating costs | 0 | 213,4 | ||
Equity capital | 0,6 | -1,2 | -1,9 | -60,3 |
Operating profit (EBIT) | 0,4 | -1,7 | -0,4 | 74,4 |
Assets | 2,3 | 3,2 | 2,6 | -18,3 |
Net profit (loss) | 0,3 | -1,8 | -0,7 | 60,7 |
Cash | 0 | 0,1 | 694,3 | |
Net income from sale | 9,7 | 10,4 | 14,3 | 37,1 |
Liabilities and provisions for liabilities | 1,7 | 4,4 | 4,6 | 2,8 |
Working assets | 0,7 | 0,5 | 0,2 | -53 |
Other income costs | 0,2 | 706,8 | ||
Depreciation | 0,3 | 0,4 | 0,4 | 23,3 |
% | % | % | p.p. | |
Profitability of capital | 53,1 | 153,4 | 37,6 | -115,8 |
Equity capital to total assets | 27,7 | -36,7 | -72,1 | -35,4 |
Gross profit margin | 4 | -17,5 | -5 | 12,5 |
EBITDA Margin | 6,9 | -12,7 | 0 | 12,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 63 | 155 | 116 | -39 |
Current financial liquidity indicator | 0.4361221492290497 | -0,3 | ||
Net dept to EBITDA | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane